$DD

Koch Lori sold $13K of DD (indirect holdings)

Koch Lori (CEO) sold 261 indirectly-held shares of DuPont de Nemours, Inc. (DD) at $48.82 on 2026-06-02.

Original reporting
SEC EDGAR · Koch Lori
Published Jun 2, 2026, 10:54 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 2, 2026, 10:58 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$DD
Neutral
low confidence
Mentioned
$DD
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$DDNeutralLow
01

Why it matters

The disclosure may marginally affect sentiment, but it does not provide new information about DuPont’s business performance or outlook.

02

Market read

A CEO reduced holdings to zero via an open-market sale disclosed today; likely limited trading impact without other catalysts.

03

What to watch

Transaction size is small ($12.7k) and does not indicate earnings, guidance, or strategic changes.

Relevance 6/10Novelty 6/10Timing: Filed today (2026-06-02) after-hours/late session disclosure

Background

SEC Form 4 reports insider ownership changes; this filing shows an officer/director selling DuPont shares.

Company-level read

Ticker impact

$DDNeutralLow confidence
Context

DuPont CEO Lori Koch filed an open-market sale of 261 shares at $48.82, leaving 0 shares, disclosed via SEC Form 4.

Expected impact

Low likelihood of a sustained price move; any reaction is likely limited to intraday sentiment/positioning.

Evidence & confidence

This is an SEC Form 4 insider transaction datapoint with no accompanying company-specific operational or financial catalyst.

Market effects

Minimal; insider transactions typically do not reset sector expectations absent broader company news.

None indicated.

None indicated.

Counterpoint

The sale could be routine liquidity/portfolio rebalancing; absence of a stated 10b5-1 plan does not prove negative fundamentals.

Key entities

  • DuPont de Nemours, Inc.

    Subject of the SEC Form 4 insider transaction; CEO Lori Koch sold shares.

  • Lori Koch

    DuPont CEO; reported open-market sale of 261 shares at $48.82.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$DDMed

DD Downgraded by JP Morgan -- Price Target Lowered to $145

JP Morgan downgraded DuPont de Nemours (DD) to Neutral, lowering its price target from $172 to $145. GuruFocus estimates DD is 83.5% overvalued, with a GF Value of $70.97 vs. current price of $130.24. DD's P/E (TTM) is 309.35x, far above its 5-year median of 7.91x. Analysts cite concerns about growth and profitability.

$DDHigh

JPMorgan downgrades DuPont stock rating on recovery outlook

JPMorgan downgraded DuPont (NYSE:DD) to Neutral from Overweight, lowering its price target to $145 from $172. The stock trades at $132.48, considered undervalued. DuPont reported Q2 2026 earnings, beating estimates with $1.88 EPS and $1.82B revenue. BMO Capital reiterated its Outperform rating, maintaining a $186 price target.

$DDMed

Attorney General Todd Rokita leads multistate coalition to stop DuPont shell game, hold companies accountable for PFAS contamination

Attorney General Todd Rokita led a 16-state lawsuit against DuPont (EIDP), Corteva, and Vylor, alleging a transfer of assets to avoid PFAS contamination liabilities. The suit seeks to freeze assets and block dividends or buybacks. Rokita claims the companies moved valuable assets to Vylor, leaving liabilities with DuPont. The hearing is set for October 2, 2026.

$DDLow

Judge says 3M, DuPont, and Honeywell must face Connecticut firefighters' PFAS claims

A U.S. judge ruled that 3M, DuPont, Honeywell, and others must face claims from Connecticut firefighters over PFAS exposure in protective gear. The lawsuit alleges the gear, containing 3M's Scotchlite and DuPont's Kevlar, increased cancer risks. The judge allowed the case to proceed, permitting damages and medical monitoring claims. The companies argue the gear served its protective function. PFAS makers face broader scrutiny, with prior settlements totaling over $11 billion.